Technology | March 11, 2010

Hemostatis Products Use Thrombin to Curb Bleeding

D-Stat Dry


Vascular Solutions offers a variety of hemostasis products used to stop bleeding. D-Stat products rely on biologically active components to induce bleeding cessation.The products use thrombin, a natural component of the clotting cascade. Thrombin cleaves fibrinogen to fibrin, enhancing the body's own ability to produce clot.

D-Stat Dry
D-Stat Dry is a topical hemostatic bandage used to control surface bleeding from vascular access sites following percutaneous procedures. It relies on the science and clotting power of thrombin to activate clotting factors VII, V and XII.

Clinical results from a 376-patient, five-center, prospective randomized U.S. clinical study showed that D-Stat Dry reduces the time to hemostasis compared with standard manual compression alone. The study evaluated D-Stat Dry as an adjunct to hemostasis in diagnostic femoral catheterizations using 4F-6F introducer sheaths.

Stat Dry Wrap
A convenient pre-cut version of D-Stat Dry, D-Stat Dry Wrap is designed specifically for the control of bleeding around indwelling lines. It contains the same thrombin activity level as the original D-Stat Dry, and comes complete with a clear adhesive bandage for continuous site monitoring after hemostasis is achieved.

Stat 2 Dry
D-Stat 2 Dry is a convenient two-bandage version of the D-Stat Dry hemostatic bandage. The pad contains the same thrombin activity level as the original D-Stat Dry, but can be separated in two for application on two separate puncture sites.

The products are contraindicated in persons with known sensitivity to bovine-derived materials.

For more information: www.vascularsolutions.com


Related Content

News | Hemostasis Management

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

Home October 27, 2021
Home
News | Hemostasis Management

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Home
News | Hemostasis Management

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

Home February 08, 2021
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
Technology | Hemostasis Management

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available ...

Home February 01, 2019
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to ...

Home August 24, 2016
Home
News | Hemostasis Management

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...

Home January 06, 2016
Home
Subscribe Now